BR9909731A - Processo para a preparação de n-metil-n[(1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)eti l]-2,2-difenilacetamida enantiomericamente puro - Google Patents

Processo para a preparação de n-metil-n[(1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)eti l]-2,2-difenilacetamida enantiomericamente puro

Info

Publication number: BR9909731A
Authority: BR; Brazil
Prior art keywords: phenyl; methyl; diphenylacetamide; ethyl; preparation
Prior art date: 1998-04-20

Application number

BR9909731-1A

Other languages

English (en)

Portuguese (pt)

Inventor

Karl-August Ackermann

Inge Stein

Rudolf Gottschlich

Bernd Helfert

Andreas Bathe

Jens Budak

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-20

Filing date

1999-04-16

Publication date

2000-12-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7865063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9909731(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-16 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2000-12-19 Publication of BR9909731A publication Critical patent/BR9909731A/pt

Links

238000000034 method Methods 0.000 title abstract 3
FBZGJUBWXHMVIT-ZEQRLZLVSA-N (3S)-4-[(3S)-3-hydroxypyrrolidin-1-yl]-2,2,3-triphenylbutanamide Chemical compound C1(=CC=CC=C1)[C@H](CN1C[C@H](CC1)O)C(C(=O)N)(C1=CC=CC=C1)C1=CC=CC=C1 FBZGJUBWXHMVIT-ZEQRLZLVSA-N 0.000 title 1
-1 (3R) -3-hydroxypyrrolidin-1-yl Chemical group 0.000 abstract 2
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 abstract 2
BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 abstract 1
JHLHNYVMZCADTC-LOSJGSFVSA-N asimadoline Chemical compound C([C@@H](N(C)C(=O)C(C=1C=CC=CC=1)C=1C=CC=CC=1)C=1C=CC=CC=1)N1CC[C@H](O)C1 JHLHNYVMZCADTC-LOSJGSFVSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
DKLYDESVXZKCFI-UHFFFAOYSA-N n,n-diphenylacetamide Chemical compound C=1C=CC=CC=1N(C(=O)C)C1=CC=CC=C1 DKLYDESVXZKCFI-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
- C07B35/02—Reduction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BR9909731-1A 1998-04-20 1999-04-16 Processo para a preparação de n-metil-n[(1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)eti l]-2,2-difenilacetamida enantiomericamente puro BR9909731A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19817393		1998-04-20
DE19827633A DE19827633A1 (de)	1998-04-20	1998-06-20	Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
PCT/EP1999/002574 WO1999054298A1 (de)	1998-04-20	1999-04-16	Verfahren zur herstellung von enantiomerenreinem n-methyl- n-[(1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid

Publications (1)

Publication Number	Publication Date
BR9909731A true BR9909731A (pt)	2000-12-19

Family

ID=7865063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9909731-1A BR9909731A (pt)	1998-04-20	1999-04-16	Processo para a preparação de n-metil-n[(1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)eti l]-2,2-difenilacetamida enantiomericamente puro

Country Status (27)

Country	Link
US (1)	US6344566B1 (de)
EP (2)	EP1607090B1 (de)
JP (1)	JP4688292B2 (de)
KR (1)	KR100649175B1 (de)
CN (2)	CN1310884C (de)
AR (2)	AR019080A1 (de)
AT (2)	ATE303361T1 (de)
AU (2)	AU761721B2 (de)
BR (1)	BR9909731A (de)
CA (1)	CA2329210C (de)
CY (1)	CY1112314T1 (de)
CZ (1)	CZ301121B6 (de)
DE (2)	DE19827633A1 (de)
DK (2)	DK1073634T3 (de)
ES (2)	ES2251194T3 (de)
HU (1)	HUP0101600A3 (de)
MY (1)	MY120471A (de)
NO (1)	NO317984B1 (de)
PL (1)	PL206969B1 (de)
PT (1)	PT1607090E (de)
RU (1)	RU2298549C2 (de)
SI (2)	SI1607090T1 (de)
SK (2)	SK288016B6 (de)
TW (1)	TWI249524B (de)
UA (1)	UA73472C2 (de)
WO (1)	WO1999054298A1 (de)
ZA (1)	ZA200006689B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10259245A1 (de) *	2002-12-17	2004-07-01	Merck Patent Gmbh	Derivate des Asimadolins mit kovalent gebundenen Säuren
JP2007509865A (ja) *	2003-10-30	2007-04-19	ティオガファーマシュウティカルズ，インコーポレイテッド	神経障害の治療における選択的オピエート受容体調節物質の使用
US20070160559A1 (en) *	2006-01-12	2007-07-12	Roszell James A	Skin disinfectant composition and methods for using
CN101677997B (zh) *	2007-03-30	2012-05-09	泰奥加制药公司	用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
CN103664727A (zh) *	2013-12-19	2014-03-26	无锡万全医药技术有限公司	一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
CN103772257A (zh) *	2013-12-31	2014-05-07	无锡万全医药技术有限公司	一种制备2-((3s)-3-羟基吡咯烷-1-基)-(1s)-1-苯乙基氨基甲酸酯的方法
US10736871B2 (en)	2015-04-01	2020-08-11	Cedars-Sinai Medical Center	Anti-methanogenic lovastatin analogs or derivatives and uses thereof
CN112574068A (zh) *	2020-11-17	2021-03-30	万华化学（宁波）有限公司	一种低色号高稳定性碳化二亚胺改性异氰酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5232978A (en) *	1988-12-23	1993-08-03	Merck Patent Gesellschaft Mit Beschrankter Haftung	1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) *	1990-11-02	1992-05-07	Merck Patent Gmbh	1-(2-arylethyl)-pyrrolidine
DE4215213A1 (de) *	1992-05-09	1993-11-11	Merck Patent Gmbh	Arylacetamide
DE4425071C2 (de) *	1994-07-15	1996-08-29	Degussa	Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit
DE19523502A1 (de) *	1995-06-28	1997-01-02	Merck Patent Gmbh	Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE19531464A1 (de) *	1995-08-26	1997-02-27	Merck Patent Gmbh	N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid
US5968968A (en) *	1996-07-24	1999-10-19	Warner-Lambert Company	Diphenyl-cyclopropenes as selective K-agonists
DE19647538A1 (de) *	1996-11-16	1998-05-20	Merck Patent Gmbh	Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[1-phenyl-2-(-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

1998
- 1998-06-20 DE DE19827633A patent/DE19827633A1/de not_active Withdrawn
1999
- 1999-04-16 AU AU40311/99A patent/AU761721B2/en not_active Ceased
- 1999-04-16 CZ CZ20003860A patent/CZ301121B6/cs not_active IP Right Cessation
- 1999-04-16 KR KR1020007011480A patent/KR100649175B1/ko not_active Expired - Fee Related
- 1999-04-16 CN CNB998052469A patent/CN1310884C/zh not_active Expired - Fee Related
- 1999-04-16 AT AT99923421T patent/ATE303361T1/de active
- 1999-04-16 SI SI9931065T patent/SI1607090T1/sl unknown
- 1999-04-16 AT AT05016750T patent/ATE527999T1/de active
- 1999-04-16 JP JP2000544639A patent/JP4688292B2/ja not_active Expired - Fee Related
- 1999-04-16 HU HU0101600A patent/HUP0101600A3/hu unknown
- 1999-04-16 DK DK99923421T patent/DK1073634T3/da active
- 1999-04-16 AR ARP990101758A patent/AR019080A1/es active IP Right Grant
- 1999-04-16 ES ES99923421T patent/ES2251194T3/es not_active Expired - Lifetime
- 1999-04-16 SI SI9930848T patent/SI1073634T1/sl unknown
- 1999-04-16 UA UA2000116543A patent/UA73472C2/uk unknown
- 1999-04-16 PL PL343556A patent/PL206969B1/pl unknown
- 1999-04-16 EP EP05016750A patent/EP1607090B1/de not_active Expired - Lifetime
- 1999-04-16 BR BR9909731-1A patent/BR9909731A/pt not_active Application Discontinuation
- 1999-04-16 SK SK5006-2008A patent/SK288016B6/sk not_active IP Right Cessation
- 1999-04-16 DK DK05016750.1T patent/DK1607090T3/da active
- 1999-04-16 WO PCT/EP1999/002574 patent/WO1999054298A1/de not_active Ceased
- 1999-04-16 EP EP99923421A patent/EP1073634B1/de not_active Expired - Lifetime
- 1999-04-16 RU RU2000128663/04A patent/RU2298549C2/ru not_active IP Right Cessation
- 1999-04-16 CN CNA2006100710951A patent/CN1846696A/zh active Pending
- 1999-04-16 SK SK1557-2000A patent/SK286442B6/sk not_active IP Right Cessation
- 1999-04-16 DE DE59912502T patent/DE59912502D1/de not_active Expired - Lifetime
- 1999-04-16 ES ES05016750T patent/ES2375384T3/es not_active Expired - Lifetime
- 1999-04-16 PT PT05016750T patent/PT1607090E/pt unknown
- 1999-04-16 CA CA002329210A patent/CA2329210C/en not_active Expired - Fee Related
- 1999-04-19 MY MYPI99001517A patent/MY120471A/en unknown
- 1999-04-20 TW TW088106298A patent/TWI249524B/zh not_active IP Right Cessation
2000
- 2000-10-19 NO NO20005259A patent/NO317984B1/no not_active IP Right Cessation
- 2000-11-16 ZA ZA200006689A patent/ZA200006689B/en unknown
2001
- 2001-01-26 US US09/647,813 patent/US6344566B1/en not_active Expired - Lifetime
2003
- 2003-09-29 AU AU2003248428A patent/AU2003248428B2/en not_active Ceased
2008
- 2008-05-06 AR ARP080101910A patent/AR066455A2/es unknown
2012
- 2012-01-05 CY CY20121100015T patent/CY1112314T1/el unknown

Also Published As

Publication number	Publication date
WO1999054298A1 (de)	1999-10-28
NO20005259L (no)	2000-10-19
PL343556A1 (en)	2001-08-27
MY120471A (en)	2005-10-31
CN1297435A (zh)	2001-05-30
DE19827633A1 (de)	1999-10-21
AU4031199A (en)	1999-11-08
JP2002512223A (ja)	2002-04-23
EP1073634B1 (de)	2005-08-31
ZA200006689B (en)	2002-02-18
SK288016B6 (sk)	2012-11-05
ES2375384T3 (es)	2012-02-29
DK1073634T3 (da)	2006-01-09
AU2003248428B2 (en)	2005-10-20
KR20010042750A (ko)	2001-05-25
PT1607090E (pt)	2012-01-10
TWI249524B (en)	2006-02-21
DK1607090T3 (da)	2012-01-30
SK286442B6 (sk)	2008-10-07
KR100649175B1 (ko)	2006-11-24
AR019080A1 (es)	2001-12-26
JP4688292B2 (ja)	2011-05-25
ES2251194T3 (es)	2006-04-16
NO317984B1 (no)	2005-01-17
ATE527999T1 (de)	2011-10-15
UA73472C2 (en)	2005-08-15
HUP0101600A2 (hu)	2001-09-28
CA2329210A1 (en)	1999-10-28
HUP0101600A3 (en)	2002-12-28
DE59912502D1 (de)	2005-10-06
ATE303361T1 (de)	2005-09-15
CA2329210C (en)	2008-03-04
SI1073634T1 (sl)	2006-02-28
RU2298549C2 (ru)	2007-05-10
SK15572000A3 (sk)	2001-05-10
US6344566B1 (en)	2002-02-05
CN1310884C (zh)	2007-04-18
CY1112314T1 (el)	2015-12-09
NO20005259D0 (no)	2000-10-19
AR066455A2 (es)	2009-08-19
CZ301121B6 (cs)	2009-11-11
EP1607090A1 (de)	2005-12-21
AU761721B2 (en)	2003-06-05
EP1607090B1 (de)	2011-10-12
SI1607090T1 (sl)	2012-01-31
AU2003248428A1 (en)	2003-11-06
HK1039111A1 (en)	2002-04-12
CN1846696A (zh)	2006-10-18
CZ20003860A3 (cs)	2001-01-17
EP1073634A1 (de)	2001-02-07
PL206969B1 (pl)	2010-10-29

Legal Events

Date	Code	Title	Description
2007-10-23	B25A	Requested transfer of rights approved	Owner name: TIOGA PHARMACEUTICALS, INC. (US) Free format text: TRANSFERIDO DE: MERCK PATENT GMBH
2009-01-06	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2009-01-06	B15K	Others concerning applications: alteration of classification	Free format text: ALTERADA DA INT. CL.: C07D 207/12; C07D 207/09; C07B 43/06; C07B 35/02. Ipc: C07D 207/12 (2008.04), C07D 207/09 (2008.04), C07B
2010-03-30	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.
2010-09-14	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

Publication	Publication Date	Title
BR0002891A (pt)	2001-01-30	Processo para a preparação de ácido (met) acrìlico
BRPI0407967A (pt)	2006-03-07	processo de uma etapa para a preparação de derivados anticonvulsivantes
BR0116739A (pt)	2003-09-30	Processo para sìntese de fenilamida do ácido 5-(4-fluorofenil)-1-[2-((2r,4r)-4-hidróxi-6-oxo-tetrahid ro-piran-2-il)-etil]-2-isopropil-4-fenil1h-pirrol-3-carb oxìlico
BR0008815A (pt)	2001-12-18	Processo para a condensação fracionada de umamistura gasosa do produto, e, coluna deseparação
BR9804437A (pt)	2001-05-02	Compostos para a osteoporose
BR0011738A (pt)	2002-03-05	Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm
DK0751939T3 (da)	2002-10-07	Naphthylamider som centralnervesystemmidler
WO2000002542A3 (de)	2000-06-22	Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum
BRPI9814894A (pt)	2000-10-03	processo para a preparação de ácidos 8-metóxi-quinolonocarboxílicos.
BR0212443A (pt)	2005-03-15	Sìntese de anéis bicìclicos fundidos, amino substituìdos enanciomericamente puros
PT879228E (pt)	2003-01-31	Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao
BR0214559A (pt)	2007-03-13	sais de ácido succìnico do 5,8,14-triazatetraciclo [10.3.1.0<2,11>.0<4,9>]-hexadeca-2(11),3,5,7,9-penteno e suas composições farmacêuticas
BR9810776A (pt)	2000-09-19	Modificação termodinamicamente estável de 1-(4-carbazolilóxi)-3-[2-(2-metoxifenóxi)etilamino]-2-pr opanol, processo para sua preparação e com- posições farmacêuticas contendo o mesmo
BRPI0518489B8 (pt)	2021-05-25	cloreto de (2r)-dotap enantiomericamente puro, seu uso, e composição farmacêutica
BR0011996A (pt)	2002-03-05	Preparação de piperidin-4-onas substituìdas
BR112012013302A2 (pt)	2016-03-01	novo processo para a preparação de tapendatol e seus intermediários
PT1237838E (pt)	2004-08-31	Novo processo
TWI249524B (en)	2006-02-21	Process for the preparation of enantiomerically pure n-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide
PT1194415E (pt)	2004-01-30	Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
BR0113236A (pt)	2005-12-13	Processo estereosseletivo para a preparação de butanos (3s,2r)-1-halo-2-hidróxi-3-(protegido)amino-4-substitu ìdos, e, processo para preparação de um composto epóxi
BR9807988A (pt)	2000-03-08	Processo para a preparação de um composto, e, composto.
BR9909290A (pt)	2000-12-05	Processo para preparar derivados de ácido 5-hidroxibenzo [b] tiofeno-3-carboxìlico
BR0001342A (pt)	2001-05-02	Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
BR9903274A (pt)	2000-05-16	Processo para isolar vitamina d3
BR0016638B1 (pt)	2013-02-05	compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.